APOLLOHOSP vs SUNPHARMA: Stock Comparison
Sun Pharmaceutical Industries Ltd is the larger company by market capitalisation. Apollo Hospitals Enterprise Ltd shows a higher ROE and faster revenue growth, while Sun Pharmaceutical Industries Ltd shows a lower P/E, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
APOLLOHOSP leads 6; SUNPHARMA leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | APOLLOHOSP | SUNPHARMA |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Pharmaceuticals |
Price
| Metric | APOLLOHOSP | SUNPHARMA |
|---|---|---|
| Live Price | ₹8,701 | ₹1,917 |
| Day Change | -0.01% | 0.37% |
| Volume | 60,780 | 4.3 L |
| 52-Week High | ₹9,050 | ₹2,046.9 |
| 52-Week Low | ₹6,696.5 | ₹1,548 |
| Distance from 52W High | -3.86% | -6.35% |
Valuation
| Metric | APOLLOHOSP | SUNPHARMA |
|---|---|---|
| Market Cap | ₹1.25 L Cr | ₹4.6 L Cr |
| P/E Ratio | 59.87x | 37.89x |
| P/B Ratio | 13.2x | 5.48x |
| EPS | ₹145.17 | ₹50.41 |
| Book Value | ₹659.33 | ₹348.31 |
| Dividend Yield | 0.23% | 0.84% |
Growth
| Metric | APOLLOHOSP | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | 18.1% | 12.8% |
| EPS Growth (TTM YoY) | 35.6% | 25.6% |
| Qtr Sales Growth | 18.1% | 10.5% |
| Qtr Profit Growth | 35.9% | 5.95% |
Profitability & Leverage
| Metric | APOLLOHOSP | SUNPHARMA |
|---|---|---|
| ROE | 22.1% | 16% |
| ROCE | 17.9% | 20.5% |
| Net Margin | 7.56% | 18.56% |
| Operating Margin | 14.9% | 29.8% |
| Debt to Equity | 0.9x | 0.06x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | APOLLOHOSP | SUNPHARMA |
|---|---|---|
| Promoter Holding | 28.02% | 54.48% |
| FII Holding | 41.5%▼ 1.12 pp | 14.53%▼ 1.4 pp |
| DII Holding | 23.72%▲ 0.96 pp | 22.18%▲ 1.07 pp |
| Public Holding | 6.54%▲ 0.17 pp | 8.81%▲ 0.33 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Apollo Hospitals Enterprise Ltd and Sun Pharmaceutical Industries Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.